Almotriptan is a raw material of triptans for the treatment of migraine.
This report contains market size and forecasts of Almotriptan Malate API in global, including the following market information:
Global Almotriptan Malate API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Almotriptan Malate API Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Almotriptan Malate API companies in 2021 (%)
The global Almotriptan Malate API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Almotriptan Malate API include FCDA, ACIC, SMS Pharmaceuticals, Tecoland, Shaoxing Hantai Pharmaceutical, OrchidPharma, Anatica pharma, Sudarshan Pharma and Clearsynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Almotriptan Malate API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Almotriptan Malate API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Almotriptan Malate API Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Almotriptan Malate API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Almotriptan Malate API Market Segment Percentages, by Application, 2021 (%)
Research
Pharmaceutical
Global Almotriptan Malate API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Almotriptan Malate API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Almotriptan Malate API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Almotriptan Malate API revenues share in global market, 2021 (%)
Key companies Almotriptan Malate API sales in global market, 2017-2022 (Estimated), (MT)
Key companies Almotriptan Malate API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
FCDA
ACIC
SMS Pharmaceuticals
Tecoland
Shaoxing Hantai Pharmaceutical
OrchidPharma
Anatica pharma
Sudarshan Pharma
Clearsynth
2A PharmaChem
CarboMer
MuseChem